(For treatment side effects and complications only)
> Acute Immunotherapy Management Guidelines> Subsequent Management Guidelines
Should further expert advice and investigations be indicated, we have identified specialists from within the Cheshire and Merseyside network who may be contacted for urgent advice and input:
Dr Rebecca Dobson
Liverpool Heart and Chest
Dr Elaine Hindle
St Helens and Knowsley (St Helens)
Dr Sid McNulty
St Helens and Knowsley (Whiston)
Dr Noshaba Naz
For CCC internal referrals:
Please Refer via Meditech
To refer into the IO Team for an Immunotherapy Related Toxicity – internal referrals should go through Meditech using the following pathway: Orders Panel – New Orders – Internal Referrals – Immunotherapy Toxicity.
Please do not refer via the paper referral form.
For referrals from services external to CCC:
Please refer to the service via the referral form and email to: email@example.com.
> Infliximab For Immune-Mediated Colitis Protocol V2.0
> Oral Methotrexate for Use in Immune Mediated Conditions Protocol V1.0
> Steroid tapering guidance V2.0
Immunotherapy alert card
There is no evidence to suggest that the flu vaccine is associated with any issues when on immunotherapy therefore we are currently recommending that people should have their flu vaccine as normal.
*If the patient is over 65 there is a new booster to the vaccine. There is no evidence about this and possible interactions with immunotherapies so having this booster therapy is not recommended
If the pneumococcal vaccine is recommended by a patients GP practice they can also receive this.
Patient should avoid live vaccines as it is unclear whether there is an increased risk with these vaccines at present (NB the nasal flu vaccine is live)